US 8344125
Modified iRNA agents
granted A61KA61K47/55A61K47/554
Quick answer
US patent 8344125 (Modified iRNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K47/55, A61K47/554, A61P, A61P31/14